Department of Paediatrics, First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Evidence-Based Medicine Center, Lanzhou University, Lanzhou, Gansu, China.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2242747. doi: 10.1080/21645515.2023.2242747.
The COVID-19 epidemic in December 2019 had a significant negative impact on people's health and economies all across the world. The most effective preventive measure against COVID-19 is vaccination. Therefore, the development and production of COVID-19 vaccines is booming worldwide. This study aimed to analyze the current state of that research and its development tendency by bibliometrics. We conducted a thorough search of the Web of Science Core Collection. VOSviewer1.6.18 was used to perform the bibliometric analysis of these papers. A total of 6,325 papers were finally included. The USA maintained a top position worldwide. Shimabukuro Tom T and Harvard University were the most prolific author and institution. The Vaccines was the most published journal. The research hotspots of COVID-19 vaccines can be classified into vaccine hesitancy, vaccine safety and effectiveness, vaccine immunogenicity, and adverse reactions to vaccines. Studies on various vaccination types have also concentrated on efficacy against continuously developing virus strains, immunogenicity, side effects, and safety.
2019 年 12 月的 COVID-19 疫情对全球各国人民的健康和经济造成了重大负面影响。预防 COVID-19 的最有效措施是接种疫苗。因此,全球范围内 COVID-19 疫苗的开发和生产正在蓬勃发展。本研究旨在通过文献计量学分析来分析该研究的现状及其发展趋势。我们对 Web of Science 核心合集进行了全面搜索。使用 VOSviewer1.6.18 对这些论文进行了文献计量分析。最终共纳入 6325 篇论文。美国在全球范围内保持领先地位。Shimabukuro Tom T 和哈佛大学是最具影响力的作者和机构。《疫苗》是发表论文最多的期刊。COVID-19 疫苗的研究热点可分为疫苗犹豫、疫苗安全性和有效性、疫苗免疫原性和疫苗不良反应。对各种疫苗类型的研究也集中在针对不断发展的病毒株的疗效、免疫原性、副作用和安全性上。